Acurx Pharmaceuticals, Inc. Common Stock

ACXPNASDAQ • USD
0.94 USD
↘ 0.03 (2.60%)AT CLOSE (03:59 PM EST)
1.05
↗ 0.11 (11.87%)
POST MARKET (AS OF 07:56 PM EST)
Post Market
AS OF 07:56 PM EST
1.05
↗ 0.11 (11.87%)
🔴Market: CLOSED

Acurx Pharmaceuticals, Inc. Common Stock (ACXP) trades at $0.93 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, ACXP appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Nov 16, 2026.

Open?$1.00
High?$1.04
Low?$0.90
Prev. Close?$0.96
Volume?119.5K
Avg. Volume?96.2K
VWAP?$0.94
Rel. Volume?1.24x
Bid / Ask
Bid?$1.04 × 100
Ask?$1.05 × 800
Spread?$0.01
Midpoint?$1.05
Valuation & Ratios
Market Cap?5.3M
Shares Out?5.6M
Float?5.4M
Float %?97.6%
P/E Ratio?N/A
P/B Ratio?0.72
EPS?-$1.48
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.
Employees
4
Market Cap
5.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2021-06-25
Address
259 LIBERTY AVENUE
STATEN ISLAND, NY 10305
Phone: 917-533-1469
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
77
Short Sent.?
59
Piotroski F-Score?0/9Weak
Altman Z-Score?-11.81Distress
Confidence?44%Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.80%Low
Short Interest?97.6K
Days to Cover?1.6
Free Float5.4M
Avg Daily Volume60.0K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.45Strong
Quick Ratio?3.45Strong
Cash Ratio?3.23Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.72CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
0.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-110.3%WEAK▾
ROA?
S&P
3
-78.3%WEAK▾
Cash Flow & Enterprise
FCF?$-6790480
Enterprise Value?$-4402087
Fundamentals ratios updated end of day